In January 2013, the United Kingdom’s National Institute for Health Research (NIHR) established eight new Healthcare Technology Co-operatives HTCs to act as centres of expertise to focus on clinical areas or themes of high morbidity and unmet needs of National Health...

As communicated on the 14th of September, a Guarantee Consortium of NOK 15 million has been established. Biovotec AS is now calling upon those Guarantees. This is a result of the successful preclinical studies which have been conducted and which now lay the basis for e...


Biovotec AS has through its preclinical studies obtained compelling results in the wound healing trials of animals which strongly indicates that the activated eggshell membrane also promotes wound healing in animals. These results have inspired Biovotec AS to establis...

Please reload

Please reload

Recent Posts
Archive
Please reload

Media Contact:     +47 95 94 99 78

Engebrets vei 3, 0275 Oslo, Norway                                                   © Biovotec AS                                                                       info@biovotec